For the sake of it... let's say there was a problem with BTX1801 where it eradicates staph, but has high recolonisation rates for whatever reason.
Considering how safe the product is, then wouldn't you simply continue treatment through the surgery to keep staph eradicated? Don't forget we are not worried about resistance anymore.
This means we sell more BTX1801. I don't see the problem.
BOT - Anything but charting, page-1880
-
- There are more pages in this discussion • 9,508 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.020(6.06%) |
Mkt cap ! $636.1M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 35.5¢ | 32.5¢ | $3.263M | 9.506M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 16367 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 99971 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |